Table 1 Demographic Parameters and Cycle Outcomes of the Groups
< 9 Oocytes (N = 404) | ≥ 9 Oocytes (N = 602) | p | |
|---|---|---|---|
Age (yrs.) | 30.1 ± 2.9 | 29.4 ± 2.9 | 0.01 |
BMI (kg/m2) | 24.5 ± 4.7 | 24.9 ± 4.2 | 0.06 |
Etiology Unexplained Tubal Anovulation Male Both Others | 29.6% 4% 12% 28% 10% 9.4% | 30% 6% 14% 25% 11% 14% | 0.4 |
FSH (IU/L) | 5.4 (4-6.8) | 5 (3.8–6.1) | < 0.01 |
Estradiol (ng/ml) | 48 (32–87) | 43 (31–68) | 0.09 |
AMH (ng/ml) | 1.6 (1-2.6) | 3.5 (2.2–5.4) | < 0.01 |
AFC (n) | 8 (6–12) | 12 (9–17) | < 0.01 |
AFC – a | 6 (4–8) | 8 (6–12) | < 0.01 |
AFC – b | 3 (1–5) | 3 (1–6) | 0.3 |
Daily Gonadotropin Dose | 302 ± 64 | 250 ± 67 | < 0.01 |
Estradiol on hCG day | 1030 (670–1644) | 2292 (1502–3368) | < 0.01 |
No. of Oocytes | 6 (4–8) | 15 (12–20) | < 0.01 |
Metaphase-2 Oocytes | 4 (2–6) | 12 (9–16) | < 0.01 |
No. of 2-Pronuclei Embryos | 2 (1–4) | 7 (5–10) | < 0.01 |